increase in government funding and initiatives for drug testing, growing awareness about drug screening in developed nations, and rising world population are some of the key factors driving the growth of the global drug screening market.
New York, NY -- (SBWIRE) -- 02/06/2017 -- North America dominates the global market for drug screening due to increase in the number of drug and alcohol abuse cases and enactment of stringent laws in the region. Asia is expected to exhibit a high growth rate in the next five years in the global drug screening market, with China and India being the fastest-growing markets in Asia Pacific. The key driving forces for the drug screening market in developing countries are the large pool of patients, growing number of drug addicts, development of advanced drug and alcohol screening devices, rising awareness regarding the significance of alcohol and drug screening, and rise in disposable income levels in the region.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/4733
Growing drug and alcohol abuse, rise in geriatric population, high consumption of alcohol and prescribed and illicit drugs, enactment of stringent laws mandating drug abuse and alcohol testing in developed countries, increase in government funding and initiatives for drug testing, growing awareness about drug screening in developed nations, and rising world population are some of the key factors driving the growth of the global drug screening market. However, accuracy issues related to breathalyzers, ban on alcohol consumption in various countries, and the fact that drug testing is considered as a violation of privacy rights in some countries, act as major restraints for the growth of the global drug screening market.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/4733
Emerging economies such as India, China, and Brazil, and oral fluid drug testing would pose opportunities for the global drug screening market.
Key segments covered in this report are:
Rapid testing devices
By sample type
Oral fluid sample
By end user
Drug testing laboratories
Drug treatment centers
Pain management centers
Top companies profiled in this report are:
Siemens Healthcare Diagnostics, Inc.
Quest Diagnostics Incorporated
Thermo Fisher Scientific, Inc.
Express Diagnostics Int'l, Inc.
Dragerwerk AG & Co. KGAA
Laboratory Corporation of America Holdings.